Title 32.1, Title 32.1. Health

A. The Council shall have a total membership of 21 members that shall consist of 18 nonlegislative citizen members and three ex officio members. The Governor shall appoint a chairman and vice-chairman who shall be residents of the Commonwealth and shall not be employed by any fed…

There is hereby created in the state treasury a special nonreverting fund to be known as the Rare Disease Council Fund, referred to in this section as "the Fund." The Fund shall be established on the books of the Comptroller. All funds appropriated for such purpose and any gifts,…

There is hereby created in the executive branch of state government the Renal Disease Council (the Council) for the purpose of (i) advising the Governor and the General Assembly on the needs of individuals with renal disease in the Commonwealth; (ii) identifying challenges that s…

The Council shall have the power and duty to: 1. Within the first year, hold public hearings and make inquiries of and solicit comments from the public to assist the Council in understanding the scope of the challenges related to renal disease in the Commonwealth and the impact o…

A. The Council shall have a total membership of 21 members that shall consist of 18 nonlegislative citizen members and three ex officio members. The Governor shall appoint a chairman and vice-chairman who shall be residents of the Commonwealth and shall not be employed by any fed…

In order to prevent disability or death, every adult resident of the Commonwealth may be offered screening tests for sickle cell disease or sickle cell trait, with an emphasis on individuals of reproductive age and individuals who are unaware of their sickle cell trait status. Th…

The Department shall establish and administer the Sickle Cell Trait Awareness and Education Program (the Program) to (i) conduct public awareness campaigns; (ii) provide educational resources; (iii) provide training to professionals, including health care providers, genetic couns…

A. Each hospital, clinic, and independent pathology laboratory shall make available to the Commissioner or his agents information on patients having sickle cell disease. A physician shall report information on patients having sickle cell disease unless he has determined that a ho…

A. Using such funds as may be appropriated therefor, the Commissioner or his designee may perform on-site data collection of the records of patients having sickle cell disease at those consenting hospitals, clinics, independent pathology laboratories, and physician offices requir…

A. The Commissioner and all persons to whom information is submitted in accordance with § 32.1-73.22 shall keep such information confidential. Except as authorized by the Commissioner in accordance with the provisions of § 32.1-41, no release of any such information shall be made…

In addition to the remedies provided in § 32.1-27, any person who uses, discloses, or releases data maintained in the statewide sickle cell disease registry in violation of § 32.1-73.24 shall be subject, in the discretion of the court, to a civil penalty not to exceed $25,000 for…

A. Any physician diagnosing sickle cell disease shall, at such time and in such manner as considered appropriate by such physician, notify each patient whose name and record abstract is required to be reported to the statewide sickle cell disease registry pursuant to § 32.1-73.22…

The Commissioner shall submit to the Governor and the General Assembly, by November 1 of each year, a report of the information obtained under this article.

A. As used in this section: "Network" means the Sickle Cell Coordinated Access Network established in this article. "Sickle cell specialist" means a health care professional who specializes in the treatment of sickle cell trait and sickle cell disease. B. The Commissioner shall e…

A. For the purposes of this section: "Endometriosis" means a systemic disease generally occurring in menstruating individuals, which may also occur in premenarchal and postmenopausal individuals. "Menstrual disorder" means any menstruation-related disorder or menstruation-related…

A. As used in this section: "Confidential substance" means any element or substance that a manufacturer has added to a menstrual product that serves a technical or functional purpose in the finished menstrual product and: 1. For which a claim has been approved by the U.S. Environ…

A. The Department, in collaboration with the Department of Behavioral Health and Developmental Services, shall develop and implement a statewide public awareness campaign on perinatal and postpartum depression. Such campaign shall: 1. Increase awareness about the symptoms, risk f…

A. The Department shall create and distribute educational materials on perinatal and postpartum depression. Such materials shall include: 1. Fact sheets on symptoms, causes, and available treatment options; 2. Contact information for local, state, and national resources, includin…

The Department shall develop and maintain an online resource hub that provides: 1. Up-to-date information on perinatal and postpartum depression; 2. A directory of mental health providers specializing in perinatal and postpartum care; 3. Information on available support groups, c…

A. The Department shall submit an annual report to the Governor and the General Assembly that includes: 1. Metrics on public engagement with the programs implemented pursuant to this article; 2. Feedback from health care providers, community organizations, and individuals served …

A. For the purposes of this section: "Severe maternal morbidity" means unintended outcomes of the process of labor and delivery that result in significant short-term or long-term consequences to a woman's health. "SMM Program" means the Severe Maternal Morbidity Surveillance and …